本页面由Tiger Trade Technology Pte. Ltd.提供服务

Propanc Biopharma, Inc.

2.27
-0.1600-6.58%
盘后2.08-0.1901-8.37%19:59 EDT
成交量:186.82万
成交额:382.38万
市值:517.19万
市盈率:-0.07
高:2.39
开:2.00
低:1.83
收:2.43
52周最高:270.25
52周最低:1.30
股本:227.84万
流通股本:26.94万
量比:0.05
换手率:693.57%
股息:- -
股息率:- -
每股收益(TTM):-32.4560
每股收益(LYR):-371.2241
净资产收益率:-126.98%
总资产收益率:-62.31%
市净率:0.53
市盈率(LYR):-0.01

数据加载中...

2025/07/31

SEC问询函

Form CORRESP - Correspondence
2025/07/31

SEC问询函

Form CORRESP - Correspondence
2025/07/30

重要事件披露

Form 8-K - Current report
2025/07/30

SEC问询函

Form CORRESP - Correspondence
2025/07/30

SEC问询函

Form CORRESP - Correspondence
2025/07/28

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/07/25

SEC问询函

Form CORRESP - Correspondence
2025/07/25

SEC问询函

Form CORRESP - Correspondence
2025/07/22

重要事件披露

Form 8-K - Current report
2025/06/27

重要事件披露

Form 8-K - Current report
2025/06/18

重要事件披露

Form 8-K - Current report
2025/06/02

重要事件披露

Form 8-K - Current report
2025/05/30

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/05/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/08

重要事件披露

Form 8-K - Current report
2025/04/25

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/04/21

重要事件披露

Form 8-K - Current report
2025/04/08

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/04/02

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/03/31

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]